Browse Articles

Discover research articles across all indexed journals

Availability and reimbursement of systemic therapies for the five most common cancers in Vietnam: A national landscape analysis.

Journal of Clinical Oncology Giang Hoang Pham, Thang Van Nguyen, Mai Thi Hoang et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.329

329 Background: Access to evidence-based systemic anticancer therapies remains uneven in many low- and middle-income countries. Vietnam faces a rising cancer burden, with breast, lung, colorectal, hepatocellular (HCC), and gastric cancers representing the five most common malignancies according to GLOBOCAN 2022. We therefore aimed to systematically assess the regulatory approval and national health insurance reimbursement status of systemic therapies recommended for these cancers in Vietnam. Methods: We performed a cross-sectional analysis of systemic anticancer drugs recommended in the latest National Comprehensive Cancer Network (NCCN) guidelines as of February 2026 for five common cancers. Regulatory and policy data were retrieved at the same time point via the official websites of the governmental regulatory authorities. Drugs were classified as chemotherapy, endocrine therapy, targeted therapy, immune checkpoint inhibitors, or antibody–drug conjugates (ADCs). For each drug, we assessed marketing authorization status, availability via import license only, and actual commercial availability. Reimbursement was assessed by cancer type and treatment intent. Results: A total of 112 systemic therapies were identified. Overall, 60 (54%) had marketing authorization, 2 (2%) were available via import license only, and 57 (51%) were available at least in one hospital in Vietnam. Detailed figures by cancer type are presented in Table 1. Chemotherapy showed the highest availability (88%), followed by endocrine therapy (80%), whereas targeted agents, immune checkpoint inhibitors and ADCs ranged from 34–40%. Among available drugs, reimbursement rates varied by cancer type and treatment intent: 70–75% in breast cancer, 63–64% in lung, 56–57% in gastric, minimal in HCC, and in colorectal cancer 100% in curative versus 38% in metastatic disease. Conclusions: This study demonstrates measurable gaps between international guideline recommendations and the availability and reimbursement of systemic therapies in Vietnam, particularly for targeted agents, immunotherapy, and ADCs. Variability in regulatory approval and insurance coverage may contribute to differences in access across cancer types and treatment settings. These findings may inform future policy discussions on optimizing regulatory processes and reimbursement frameworks to enhance equitable access to cancer treatment. Regulatory status and availability of recommended systemic therapies in Vietnam. Cancer type Recommended Registeredn (%) Import license onlyn (%) Availablen (%) Breast 54 35 (65) 1 (2) 32 (59) Lung 57 26 (46) 2 (4) 27 (47) HCC 18 9 (50) 1 (6) 10 (56) Gastric 25 13 (52) 2 (8) 15 (60) Colorectum 33 15 (45) 2 (6) 16 (48)

Enantioselective Total Syntheses of (+)-Aconicarmichinium C and (+)-Pendulumine I: Strategic Use of a Bridgehead Enone via a Kinetic-Resolution-Enabled Intermolecular Diels–Alder Reaction

Journal of the American Chemical Society Wenhao Zhang, Qilin Xue, Dawei Ma et al. Jul 01, 2026 DOI: 10.1021/jacs.6c06155

Adaptive Restructuring toward Intrinsically Stable Rh Catalyst during Water–Gas Shift Reaction

Angewandte Chemie International Edition Yuanjie Xu, Yi‐Chun Chu, Run Hou et al. Jul 01, 2026 DOI: 10.1002/anie.5021940

ABSTRACT Achieving intrinsic stability of reaction‐formed catalytic sites, and understanding its origin, remains a central challenge in heterogeneous catalysis. Although CO‐driven restructuring of atomically dispersed metals into subnanometer clusters has been observed in methane reforming and related reactions, the electronic basis of the resulting stability and the catalytic mechanism on these sites remain unknown. In this study, we show that atomically dispersed Rh on CeO 2 nanorods spontaneously evolves into Rh 3 (CO) 4 clusters during the water–gas shift (WGS) reaction, and that this restructuring resolves the inherent activity–stability trade‐off. Metastable Rh 3 (CO) 3 clusters with higher initial activity transform into thermodynamically stable Rh 3 (CO) 4 that sustains performance over 5000 h at 300°C without apparent deactivation. Combining in situ spectroscopy, kinetic analysis, and density functional theory calculations, we reveal the dual origins of this intrinsic stability. Coordination of the fourth CO ligand lowers the cluster formation energy by 2.15 eV, driven by ‐π* hybridization through Rh‐to‐CO back‐donation, rendering Rh 3 (CO) 4 a thermodynamic sink resilient to reaction‐induced perturbations. Meanwhile, surface hydride species generated at oxygen vacancies open a concerted COOH dehydrogenation pathway, markedly lowering the rate‐determining barrier. This work demonstrates that reactive atmospheres can steer catalytic sites toward configurations where structural stability and catalytic function coexist.

Effect of platelet-rich plasma on pain, function, and graft maturation after anterior cruciate ligament reconstruction: a prospective, randomized controlled trial

Scientific Reports Minghua Zhang, Dongfeng Chen, Changrui Zhong et al. Jul 01, 2026 DOI: 10.1038/s41598-026-59714-1

Technologies to measure and modulate protein subcellular localization

Nature Reviews Molecular Cell Biology William Leineweber, Reika Tei, Anna Mäkiniemi et al. Jul 01, 2026 DOI: 10.1038/s41580-026-00957-1

Excitation Dependent Nonconventional Afterglow for 6D Dynamic Encryptions

Advanced Materials Shu‐Yue Yang, Wen‐Ting Wu, Guang‐Yue Li et al. Jul 01, 2026 DOI: 10.1002/adma.73602

ABSTRACT Nonconventional luminescent materials without traditional aromatic chromophores have attracted significant research interest. However, achieving persistent luminescence under visible‐light excitation in those systems is inherently difficult. Herein, we report a simple and general strategy to develop intrinsic excitation‐dependent afterglow in aliphatic polyesters via hybridization with metaboric acid (MBA), in which the afterglow peak shifts from 431 to 540 nm upon tuning the excitation source from 254 to 405 nm, owing to the formation of clusters with varied sizes during the fabrication. Moreover, the afterglow emission color could be tuned from deep blue to red via triplet‐to‐singlet Förster resonance energy transfer (TS‐FRET) by doping with a commercial dye. These inorganic‐polymer composites could be fabricated into 3D artwares and multi‐mode anti‐counterfeiting labels. Leveraging the multicolor afterglow and spatial manipulation, a 6D dynamic encryption platform using a luminescent magic cube was demonstrated. This work not only provided a novel composite‐induced strategy for creating intrinsic excitation‐dependent afterglow from aliphatic polyesters but also successfully demonstrated their pioneering application in advanced information encryption.

Adebrelimab combined with oral etoposide for older patients and patients with poor performance status In small cell lung cancer: A multicenter, open-label, phase II clinical study.

Journal of Clinical Oncology Fang Liu, Meng Hong Xue, Yan Zhang et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.tps293

TPS293 Background: Small cell lung cancer (SCLC) is a highly aggressive, high-grade neuroendocrine carcinoma characterized by rapid proliferation and early metastatic dissemination. Recent research has demonstrated that adebrelimab plus platinum-based chemotherapy have demonstrated promising anti-tumour activity in first-line treatment of SCLC in CAPSTONE-1 trial. However, a substantial proportion of patients—particularly older patients and those with poor performance status (ECOG PS ≥2) or significant comorbidities—cannot tolerate standard platinum-based regimens due to reduced tolerance to systemic therapy. In such cases, oral etoposide is an active single-agent option. Therefore, this study aims to evaluate the efficacy and safety of adebrelimab combined with oral etoposide as a first-line treatment for SCLC in older patients and those with poor performance status. Methods: In this multicenter, open-label, phase II trial, 47 patients with extensive-stage SCLC or limited-stage, diagnosed histologically or cytologically, and who are treatment-naive are anticipated to be enrolled. Key inclusion criteria are: age≥65 years, or an Eastern Cooperative Oncology Group performance status of 2 or 3, an expected life expectancy of at least 3 months, and adequate organ function, not indicated for curative surgery or chemoradiotherapy. Additionally, patients aged < 65 years with an ECOG PS of 0-1 may be considered if they have extensive comorbidities. Key exclusion criteria included risk of bleeding, uncontrolled hypertension, uncontrolled effusions, active serious infections, autoimmune disease, or uncontrolled symptomatic brain metastases. Patients will be dosed adebrelimab (1200 mg, iv, every 3 weeks) in combination with oral etoposide (75 mg, po, once daily). The primary endpoint is progression-free survival and the secondary endpoints are objective response rate, disease control rate, overall survival, safety and quality of life. The study is actively recruiting. Clinical trial information: NCT07398560 .

Generation of the Camptothecin Scaffold by a Flavin‐Catalyzed Photooxidative Skeletal Reorganization

Angewandte Chemie International Edition Shenyu Liu, Zeliang Zhang, Benedikt Seligmann et al. Jul 01, 2026 DOI: 10.1002/anie.4569029

ABSTRACT The plant alkaloid camptothecin is a high‐value precursor for the semi‐synthesis of multiple anticancer drugs. The key transformation during its biosynthetic pathway is a yet enigmatic skeletal reorganization from a 6/5/6 tetrahydro‐β‐carboline ring system to the 6/6/5 pyrroloquinoline scaffold, which is characteristic of camptothecin‐related alkaloids. Here, we show that this scaffold transition can be efficiently catalyzed by flavin cofactors such as flavin mononucleotide in a photooxidative process. As part of this complex transformation, we verified the existence of a previously postulated macrocyclic ketolactam intermediate. Based on the mild conditions—oxygen, light, and flavins—we show that this conversion can also take place in leaves of Nicotiana benthamiana , a plant which does not normally produce camptothecin or related alkaloids. Our optimized biomimetic photochemical reaction conditions enable a short, mild, and efficient semi‐synthesis of the alkaloids (3 S )‐pumiloside, (3 R )‐pumiloside, and vincosamide ketolactam, also known as turpiniside, without any protecting groups. Thus, our work improves our understanding of this key skeletal reorganization step forming the camptothecin scaffold in nature and provides streamlined photocatalytic access to camptothecin‐related alkaloids.

Self-adaptive cyber deception and resilient network defense via adversarial environment simulation

Scientific Reports Rajeshwari Ramaraj, Umarani Govindasamy Jul 01, 2026 DOI: 10.1038/s41598-026-59245-9

Abstract In the dynamic world of cybersecurity, the attacker is constantly innovating his methods of attack while taking advantage of vulnerable unknown to defender reactive defense is increasingly inadequate. This paper presents a novel approach for proactive cyber defense- autonomous system, which combines cyber deception, adversarial environment simulation, and self-adaptive reinforcement intelligence. At the core of this approach are dynamic and life-like attack vectors created through Generative Adversarial Networks (GANs) to mimic real-world zero-day and polymorphic threats. These artificially adversarial scenarios make the training environment very unstable for the DRL agent in the sense it has to learn robust context aware defense policies when the enemy is changing its attack strategies on the fly. Through a sequence of sustained exchange with GAN-generated environment, the DRL agent can be trained to identify malice with a non-trivial set of malware behaviors beyond finite rules or static signatures. Whereas traditional IDS/IPS solutions (i.e., performed respectively after-the-fact and by rule-based actions) simply aim to mitigate an attack, the latter moves the goalposts by transforming the surface of attack-defense continuously into a battlefield, and by employing, among others, deception nodes, re-routing detection vectors, and risk posture adaptation as the threat context changes. The observer is not only robust to novel attacks but also triggers deceptive traps on the attacker and confounds attackers’ inference paths, leading to increased robustness as well as lower false alarms and reduced compromise-recovery time. We run our method on a synthetic smart-grid network where we inject good and adversarial traffic into the network so that we can evaluate the resilience under multiple attack scenarios in a fine-grained manner. Empirical study in various network scenarios shows that the effectiveness of proactive threat detection, defense strategy optimization and recovery performance can be significantly improved MTTC by approximately 4.5× compared to static IDS, while reducing FPR by over 75%, demonstrating substantial gains in both detection reliability and response efficiency. The proposed model serves as a cornerstone toward the development an autonomous, digital immune system that learns, evolves, and turns even the most lethal forms of malware, ransomware, and zero-day attacks into benign files without human intervention—to move from static defense to dynamic, intelligent cyber-resilience.

Liver resection in a resource-limited setting: Outcome of developed-world standards of R0 resection and 30-day mortality without a dedicated ICU or advanced technology—A real-world data analysis from Sri Lanka.

Journal of Clinical Oncology Sampath Hirantha Herath, Niroshan S. Atulugama, Chathuri udeshika Goonetilleke et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.344

344 Background: Liver resection with curative intent offers a chance of long-term survival for patients with hepatic malignancies. In many low- and middle-income countries (LMICs), including Sri Lanka, wider adoption of these procedures is limited by the scarcity of specialized centres, advanced technology, and dedicated intensive care units (ICUs). This study examines the outcomes of complex liver resections performed at a non-specialist peripheral hospital in Sri Lanka operating under significant resource constraints. Our objective was to assess whether liver resections carried out in a resource-limited centre in an LMIC can achieve R0 resection and 30-day mortality outcomes comparable to benchmarks reported from high-income settings. Methods: We conducted a retrospective study on a cohort of consecutive patients who underwent liver resection for primary or secondary hepatic malignancies at a single peripheral centre over a two-year period (February 2024 to January 2026). Patients with benign disease were excluded. All operations were performed without hepatic inflow occlusion (no Pringle maneuver). An R0 resection was defined as a microscopically clear margin of at least 1 mm. Primary outcomes were the R0 resection rate and 30-day mortality. Results: Of 41 patients identified, 39 met the inclusion criteria after exclusion of two patients with benign cysts. Overall, 57.1% had primary liver cancers and 42.9% had secondary metastases. Major liver resections were performed in 52.6% of patients and minor resections in 47.4%. Intra-operative transfusion of more than two units of blood was required in 18.0% of cases. Postoperatively, 51.4% of patients had an ICU stay of three days or less. An R0 resection was achieved in 71.8% (n = 28), while 28.2% (n = 11) had an R1 resection. The overall 30-day mortality rate was 10.3% (n = 4). 66.7% were alive at 30 days and had a R0 resection. There was no statistically significant association between R0 resection status and 30-day mortality (p = 0.307). Conclusions: In this real-world series from a resource-limited LMIC setting, complex liver resections achieved R0 resection rates and 30-day mortality outcomes comparable to published benchmarks from high-income countries. The lack of a statistically significant relationship between margin status and early mortality indicates that an assertive approach to securing clear margins appears safe and does not adversely affect short-term postoperative outcomes, even in the absence of a dedicated ICU and advanced technology.

Hydrophobic Promoter‐Enhanced Tandem Catalysis for Alkene Epoxidation With H <sub>2</sub> and O <sub>2</sub>

Angewandte Chemie International Edition Defu Yin, Jiamin Yuan, Dong Lin et al. Jul 01, 2026 DOI: 10.1002/anie.2551607

ABSTRACT The efficiency of tandem catalysis is fundamentally limited by the transport of transient intermediates. In the direct epoxidation of alkenes with H 2 and O 2 , in situ generated H 2 O 2 rapidly decomposes during diffusion, rendering most Ti active sites kinetically inaccessible and imposing a long‐standing performance ceiling. Here, we overcome this limitation by engineering hydrophobic transport channels via physical integration of a hydrophobic polymer with bifunctional Au/TS‐1 catalysts. This microenvironment accelerates H 2 O 2 migration away from hydroxyl‐rich surfaces toward remote Ti sites while suppressing nonproductive decomposition. Molecular dynamics simulation studies show that the diffusion of H 2 O 2 on hydrophobic surfaces is significantly higher than on hydrophilic surfaces, as reflected experimentally by a 25% increase in tandem H 2 O 2 efficiency. Moreover, the hydrophobic channels promote rapid desorption of epoxide products, suppressing ring‐opening reactions and carbonaceous accumulation, resulting in a stable ∼90% epoxide selectivity over 200 h. This strategy exhibits broad generality across Au–Ti bifunctional catalysts for alkene epoxidation using in situ generated H 2 O 2 , with an outstanding H 2 utilization efficiency of 73.5% achieved over the Au/TS‐1‐B catalyst under the identical standard reaction conditions employed throughout this work. This work establishes diffusion control of metastable surface species as a principle for breaking intrinsic transport–decomposition trade‐offs in tandem catalysis.

BIBOP‐Catalyzed Asymmetric Staudinger/aza‐Wittig Reaction: Unified Syntheses of (–)‐Minfiensine and (+)‐Aspidophylline A

Angewandte Chemie International Edition Zhen Dong, Zhengwen Xue, Zhuoping Deng et al. Jul 01, 2026 DOI: 10.1002/anie.5183787

ABSTRACT A unified approach has been developed to construct the characteristic 4a,9a‐heterocycle‐fused tetrahydrocarbazole skeleton present in various monoterpene indole alkaloids. This method hinges on a unique chiral bisphosphine BIBOP‐catalyzed asymmetric Staudinger/aza‐Wittig reaction followed by imine cyclization. Compared to conventional mono‐ and bisphosphines, BIBOP exhibits more robust performance across diverse reaction settings. Mechanistic studies revealed that BIBOP(O), the mono‐oxidized derivative of BIBOP, could also promote the asymmetric transformation with excellent enantioselectivity. Leveraging the developed method, we have accomplished a concise total synthesis of (–)‐minfiensine and a formal synthesis of (+)‐aspidophylline A. This work not only establishes a versatile platform for the synthesis of diverse monoterpene indole alkaloids but also offers a new class of organophosphine catalysts applicable to asymmetric Staudinger/aza‐Wittig reaction as well as related transformations.

Simulation-based assessment of solar-integrated systems for climate-resilient residential buildings in semi-arid regions

Scientific Reports Reza Yeganeh Khaksar, Erfan Saket, Aamir Mahmood et al. Jul 01, 2026 DOI: 10.1038/s41598-026-60328-w

Real-world outcomes of first-line afatinib in advanced non–small cell lung cancer patients with uncommon EGFR mutations at Vietnam National Cancer Hospital.

Journal of Clinical Oncology Anh Tuan Nguyen Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.277

277 Background: Uncommon EGFR mutations represent a heterogeneous subgroup of non–small cell lung cancer (NSCLC) with variable responses to EGFR tyrosine kinase inhibitors (EGFR-TKIs). Real-world data, particularly from Vietnam, remain limited. This study aimed to evaluate treatment outcomes in advanced NSCLC patients harboring uncommon EGFR mutations. Methods: This retrospective single-center study included 87 patients with stage IIIC–IV lung adenocarcinoma carrying uncommon EGFR mutations treated at Vietnam National Cancer Hospital between January 2018 and September 2024, with follow-up until September 2025. Results: A total of 87 patients were enrolled, with a mean age of 61.6 ± 8.6 years. The distribution of EGFR mutations showed a predominance of major uncommon mutations (78,2%; group 1), followed by other rare uncommon mutations (14,9%; group 2), and exon 20 insertions/duplications (6,9%; group 3). The overall objective response rate (ORR) for the entire cohort was 62.1%, and the disease control rate (DCR) was 80.5%. When analyzed by mutation subgroup, the ORR in group 3 was significantly lower than in groups 1 and 2 (12.5% vs. 66.7% and 70.0%, respectively; p &lt; 0.05), while no significant difference was observed between groups 1 and 2 ( p &gt; 0.05). With a median follow-up of 28.1 ± 1.4 months, the median progression-free survival (mPFS) for the entire cohort was 11.3 ± 0.9 months. The mPFS for groups 1, 2, and 3 was 12.1 ± 1.3 months, 10.3 ± 3.2 months, and 3.0 ± 2.2 months, respectively. Pairwise log-rank analysis demonstrated a statistically significant difference in PFS between groups 1 and 3 (χ² = 4.846, p = 0.028). No significant differences were observed between groups 1 and 2 ( p = 0.176) or between groups 2 and 3 ( p = 0.215). The median overall survival (OS) for the entire cohort was 22.9 ± 3.1 months. Following disease progression,69% of patients received subsequent systemic therapy, most commonly platinum-based chemotherapy and/or third-generation EGFR-TKIs. Patients with exon 20 insertions were more likely to receive chemotherapy. Conclusions: Afatinib shows favorable efficacy in advanced NSCLC patients with uncommon EGFR mutations, particularly in non–exon 20 insertion subgroups, while exon 20 insertions are associated with poorer outcomes, indicating the need for alternative treatment strategies in this population. Distribution of uncommon EGFR mutation subtypes (n = 87). Major uncommon mutations 68 78,2% G719X 20 23% G719X + S768I 19 21,8% G719X + E709X 4 4,6% G719X + L861Q 3 3,4% G719X + D761Y 1 1,1% L861Q 17 19,5% L861Q + V834L 1 1,1% S768I 3 3,4% Other rare mutations 13 14,9% E709_T710delins 3 3,4% A750P 1 1,1% D761N + D855N 1 1,1% E734Q 1 1,1% L747S 2 2,3% L833V + H835L 1 1,1% T263P 1 1,1% V786M 1 1,1% H773L + V774M 2 2,3% Exon20ins/dup 6 6,9% A767_V769dup 4 4,6% I740_K745dup 1 1,1% S768_D770dup 1 1,1%

Asymmetric Ionic Liquid Modulated Anion‐Reinforced Electric Double Layer for Advanced Durable Lithium Batteries

Angewandte Chemie International Edition Taohong He, Zhuangzhuang Zhang, Kaiyan Wu et al. Jul 01, 2026 DOI: 10.1002/anie.5759017

ABSTRACT The electric double layer (EDL) governs local electrolyte enrichment and reduction pathways, thereby directing the nucleation and evolution of solid electrolyte interphase (SEI). However, electrolyte design is still largely guided by bulk solvation descriptors. Here, an asymmetric room temperature phosphonium ionic liquid, (2‐methoxyethoxy)methyl phosphonium hexafluorophosphate (PMEP), is designed to promote an anion‐reinforced EDL. Molecular asymmetry lowers the melting point of PMEP and promotes PF 6 − participation in Li + ‐centered solvation structures. Molecular dynamics (MD) simulations and density functional theory (DFT) calculations suggest that PF 6 − can participate in Li + ‐centered interfacial solvation clusters under selected charge states, which contributes to the formation of an SEI containing both organic reduction products and inorganic species such as LiF and Li 2 O. This organic/inorganic SEI structure lowers interfacial impedance and the apparent activation barrier for Li + transfer, enabling more uniform lithium deposition and a mechanically robust interface. Li|LiFePO 4 batteries with an areal loading of 11.3 mg cm −2 deliver 94.9% capacity retention after 600 cycles. The fabricated 1.6 Ah Graphite|LiFePO 4 cylindrical cell operates stably for over 500 cycles with a Coulombic efficiency above 99.8%. This work demonstrates a shift in electrolyte design from bulk formulations toward interfacial solvation structure engineering for next generation batteries.

Identification of DNA sequence variants in the Vasculo-Behcet disease patient using whole exome sequencing: a pilot study from Pakistan

Scientific Reports Ayesha Waqas, Azra Yasmin, Christopher Mark Watson et al. Jul 01, 2026 DOI: 10.1038/s41598-026-58605-9

Nimotuzumab combined with induction chemotherapy and concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: A prospective, multicenter, randomized controlled trial—Preliminary analysis.

Journal of Clinical Oncology Chen Xi Shan, Wu Yu Zhen, Lu Ying Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.238

238 Background: To evaluate nimotuzumab combined with standard chemoradiotherapy in locally advanced nasopharyngeal carcinoma (NPC). Methods: This prospective, multicenter, randomized trial enrolled 172 patients with stage III-IVa NPC across 8 hospitals in Guangxi (NCT05717790). Patients were randomly assigned (1:1) to receive either standard therapy (2 cycles of gemcitabine/cisplatin induction followed by cisplatin-based CCRT) or nimotuzumab plus standard therapy (200mg weekly during induction, then 200mg every 3 weeks for 8 cycles as maintenance). The primary endpoint was 5-year overall survival; secondary endpoints included response rates, safety, and quality of life. Results: At interim analysis, induction chemotherapy yielded comparable objective response rates (ORR) between groups for primary tumor (88.2% vs 87.4%, P = 0.860) and lymph nodes (70.6% vs 80.5%, P = 0.132). After CCRT and maintenance therapy, the nimotuzumab group achieved significantly higher complete response rate (22.35% vs 10.34%, P = 0.033) with similar ORR (P &gt; 0.05). At 2 years, both groups showed excellent outcomes: overall survival 100% in both; progression-free survival 99.0% vs 97.1%; distant metastasis-free survival 99.0% vs 98.2%; locoregional relapse-free survival 100% vs 99.0%. Grade 3-4 neutropenia (8.2% vs 0%, P = 0.006) and thrombocytopenia (5.9% vs 0%, P = 0.022) were more common with nimotuzumab, but other toxicities were similar between groups. Conclusion: Adding nimotuzumab to standard induction chemotherapy and CCRT significantly improved complete response rates in locally advanced NPC. Increased myelosuppression was manageable. Long-term survival data are pending. Clinical trial information: NCT05717790 .

AND‐Logic‐Gated Aptamer Switch for Precise Targeting and Regulation of RNA G‐Quadruplexes

Angewandte Chemie International Edition Dan Wang, Ying Feng, Chun Kit Kwok Jul 01, 2026 DOI: 10.1002/anie.4594145

ABSTRACT RNA G‐quadruplexes (rG4s) play critical roles in gene regulation and cancer progression, yet their precise manipulation in tumor cells remains challenging. rG4‐targeting L‐RNA aptamers are an emerging class of ligands with exceptional affinity for rG4s; however, their lack of cell type‐specific delivery hinders their regulatory and therapeutic potential. Herein, we engineer an activatable bispecific aptamer switch, termed the Allosteric RNA G‐quadruplex ON‐switch (ARGON), which integrates an rG4‐targeting L‐RNA Apt.4‐1c module (masked by a glutathione (GSH)‐cleavable lock strand) with a tumor receptor‐targeting Sgc8 DNA aptamer to precisely target rG4s and regulate downstream cellular activities within tumor cells. The AND logic‐gated ARGON is activated exclusively in tumor cells that exhibit both tumor receptor overexpression and elevated GSH levels. Following cellular uptake, GSH‐triggered lock cleavage exposes L‐Apt.4‐1c's rG4‐binding domain, enabling binding oncogenic Bcl2 rG4. Then activated ARGON regulates rG4‐associated tumor cellular functions while sparing normal cells. Besides, we apply ARGON to target human telomerase RNA component ( hTERC ) rG4 to show our method's generality. Collectively, by integrating cell‐surface addressing with intracellular environmental sensing, our work reports an “old‐chemistry‐new‐trick” framework for regulating nucleic acid structures, enabling conditional targeting of cellular RNA structures with minimal off‐target effects and propelling aptamer‐based precision biomedicine forward.

A multimodal learning framework for Arabic handwritten word recognition and future research directions

Scientific Reports Jawad Hasan Alkhateeb Jul 01, 2026 DOI: 10.1038/s41598-026-59980-z

Ultrathin Li Metal Anodes: Quantitative Design Principles and Manufacturability Across Liquid and Solid‐State Batteries

Advanced Materials Cheng Wang, Caoyu Wang, Shuixin Xia et al. Jul 01, 2026 DOI: 10.1002/adma.73568

ABSTRACT Li metal anode shows significant potential for advancing high‐energy‐density and commercially viable lithium batteries due to its high specific capacity and low electrochemical potential. However, thinning Li metal encounters serious challenges owing to its mechanical stickiness and fragility during the mechanical rolling process, which severely restricts its practical utilization. Consequently, most current Li metal batteries rely on excessively thick Li foils, leading to substantial resource waste and undermining the pursuit of high energy density. This review highlights the quantitative design principles of ultrathin Li metal (≤15 µm) and elucidates its critical roles in realizing the true potential of Li metal batteries. Emerging strategies for the fabrication of ultrathin Li metal, followed by a critical evaluation of recent advances and persistent challenges in their deployment for both liquid and solid‐state batteries, are summarized. A perspective on future directions for ultrathin Li metal is also presented. Ultrathin Li metal anodes are poised to deliver transformative improvements in energy density, unlocking new opportunities for advanced energy storage systems.